NCT00411450 Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment Status COMPLETED Phase PHASE2
NCT00398879 Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients Status COMPLETED Phase PHASE2
NCT00393822 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00381173 A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing Status COMPLETED Phase PHASE1
NCT00354705 Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients Status UNKNOWN Phase N/A
NCT00351572 Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients Status COMPLETED Phase N/A
NCT00337389 Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. Status UNKNOWN Phase PHASE3
NCT00336856 Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy Status COMPLETED Phase PHASE2
NCT00335504 Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia Status COMPLETED Phase PHASE2
NCT00332163 Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy Status COMPLETED Phase PHASE2
NCT00250328 Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy Status UNKNOWN Phase PHASE1
NCT00245492 Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening. Status COMPLETED Phase NA
NCT00235898 Clinical Trial in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2